Počet záznamov: 1

brentuximab vedotin

SYS		d000079963
LBL		00000nx^^^2200181-^^45^^
005		20240119195337.8
100		$a 20200101asloy0103 ba0
152		$b mesh
250		$a brentuximab vedotin $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo
300	1-	$a 2020 (2010) $8 eng
330	1-	$a Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA. $8 eng
450		$a brentuximab vedotín $5 e $8 slo
450		$a Adcetris $5 e $8 slo
686		$a D12.644.456.217
686		$a D12.776.124.486.485.114.224.060.438
686		$a D12.776.124.790.651.114.224.060.469
686		$a D12.776.377.715.548.114.224.200.469
750		$a Brentuximab Vedotin $8 eng
801	-0	$a SK $b BA006 $c 20200216
801	-2	$a SK $b BA006 $c 20200304
980		$x M

Počet záznamov: 1